Quick Answer
Medicus Pharma Ltd. reported Stockholders Equity of -$67.6 thousand for fiscal year 2025.
Medicus Pharma Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$67.6K | -102.2% |
| 2024 | $3.13M | +182.0% |
| 2023 | $1.11M | +109.1% |
| 2022 | -$12.19M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$910.1K | -119.0% | -128.0% |
| June 30, 2025 | $3.25M | -54.1% | +51.3% |
| March 31, 2025 | $2.15M | +483.5% | -31.5% |
| December 31, 2024 | $3.13M | +182.0% | -34.6% |
| September 30, 2024 | $4.79M | — | -32.2% |
| June 30, 2024 | $7.07M | — | +1363.2% |
| March 31, 2024 | -$560.0K | — | -150.4% |
| December 31, 2023 | $1.11M | — | — |
- Medicus Pharma Ltd. showed a decrease of -102.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Medicus Pharma Ltd.’s stockholders equity has grown by 99.4% (from -$12.19 million to -$67.6 thousand).
- The most recent figure is from Medicus Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: